Pharmacological management of persistent pain in older persons

Journal of Pain

Volumn 12, Issue 3 SUPPL., 2011, Pages

  Reisner, Lori ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Analgesics; neuropathic pain; number needed to harm; number needed to treat; safety

Indexed keywords

AMITRIPTYLINE; ANALGESIC AGENT; BENZODIAZEPINE DERIVATIVE; CAPSAICIN; CLONIDINE; DESIPRAMINE; DEXMEDETOMIDINE; DEXTROMETHORPHAN; DOXEPIN; DULOXETINE; GABAPENTIN; IMIPRAMINE; INDOMETACIN; KETAMINE; LIDOCAINE; MILNACIPRAN; NAPROXEN; NONSTEROID ANTIINFLAMMATORY AGENT; NORTRIPTYLINE; OPIATE DERIVATIVE; OXAPROZIN; OXCARBAZEPINE; PETHIDINE; PIROXICAM; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; TIZANIDINE; TOPIRAMATE; TRICYCLIC ANTIDEPRESSANT AGENT; TRYPTOPHAN; UNINDEXED DRUG;

ADJUVANT THERAPY; ANTICHOLINERGIC EFFECT; ARTICLE; BLURRED VISION; CENTRAL NERVOUS SYSTEM DISEASE; COGNITIVE DEFECT; COMORBIDITY; CONSTIPATION; DELIRIUM; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG OVERDOSE; DRUG POTENTIATION; DRUG SAFETY; DRUG TARGETING; DRUG TRANSFORMATION; FALL RISK; FALLING; FRACTURE; GERIATRICS; HEALTH CARE PLANNING; HEART ARRHYTHMIA; HUMAN; MEMBRANE STABILIZATION; NEUROPATHIC PAIN; NOCICEPTION; ORTHOSTATIC HYPOTENSION; PAIN; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRESCRIPTION; RISK ASSESSMENT; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SYNCOPE; TACHYCARDIA; TREATMENT PLANNING; UNSPECIFIED SIDE EFFECT; URINE RETENTION; XEROSTOMIA;

AGED; AGING; ANALGESIA; ANALGESICS; HUMANS; PAIN, INTRACTABLE;

EID: 79952480661     PISSN: 15265900     EISSN: 15288447     Source Type: Journal    
DOI: 10.1016/j.jpain.2011.01.001     Document Type: Article

References (58)

1. M. Adams, H.J. Pieniaszek Jr., A.R. Gammaitoni, and H. Ahdieh Oxymorphone extended release does not affect CYP2C9 or CYP3A4 metabolic pathways J Clin Pharmacol 45 2005 337 345 (Pubitemid 40490430)
2. AGS Panel on Persistent Pain in Older Persons The management of persistent pain in older persons J Am Geriatr Soc 50 2002 S205 S224
3. American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons Pharmacological management of persistent pain in older persons J Am Geriatr Soc 57 2009 1331 1346
4. N. Arden, and M.C. Nevitt Osteoarthritis: Epidemiology Best Pract Res Clin Rheumatol 20 2006 3 25 (Pubitemid 43230460)
5. M. Backonja, M.S. Wallace, E.R. Blonsky, B.J. Cutler, P. Malan Jr., R. Rauck, and J. Tobias NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: A randomised, double-blind study Lancet Neurol 7 2008 1106 1112
6. N.H. Ballentine Polypharmacy in the elderly: Maximizing benefit, minimizing harm Crit Care Nurs Q 31 2008 40 45 (Pubitemid 351640117)
7. R. Baron, V. Mayoral, G. Leijon, A. Binder, I. Steigerwald, and M. Serpell 5% lidocaine medicated plaster versus pregabalin in post-herpetic neuralgia and diabetic polyneuropathy: An open-label, non-inferiority two-stage RCT study Curr Med Res Opin 25 2009 1663 1676
8. L. Bertilsson Metabolism of antidepressant and neuroleptic drugs by cytochrome p450s: Clinical and interethnic aspects Clin Pharmacol Ther 82 2007 606 609 (Pubitemid 47622529)
9. Biovail Corporation. Ultram ER prescribing information. Available at: http://www.ultram-er.com/ultram-er/full-product-info.html. Accessed July 9, 2009
10. M.J. Caterina, M.A. Schumacher, M. Tominaga, T.A. Rosen, J.D. Levine, and D. Julius The capsaicin receptor: A heat-activated ion channel in the pain pathway Nature 389 1997 816 824 (Pubitemid 27462969)
11. Cepeda MS, Camargo F, Zea C, Valencia L: Tramadol for osteoarthritis. Cochrane Database Syst Rev 3:CD005522, 2006
12. A.S. Chappell, G. Littlejohn, D.K. Kajdasz, M. Scheinberg, D.N. D'Souza, and H. Moldofsky A 1-year safety and efficacy study of duloxetine in patients with fibromyalgia Clin J Pain 25 2009 365 375
13. M.L. Chew, B.H. Mulsant, B.G. Pollock, M.E. Lehman, A. Greenspan, R.A. Mahmoud, M.A. Kirshner, D.A. Sorisio, R.R. Bies, and G. Gharabawi Anticholinergic activity of 107 medications commonly used by older adults J Am Geriatr Soc 56 2008 1333 1341
14. R. Chou, J.C. Ballantyne, G.J. Fanciullo, P.G. Fine, and C. Miaskowski Research gaps on use of opioids for chronic noncancer pain: Findings from a review of the evidence for an American Pain Society and American Academy of Pain Medicine clinical practice guideline J Pain 10 2009 147 159
15. R. Chou, S. Carson, and B.K. Chan Gabapentin versus tricyclic antidepressants for diabetic neuropathy and post-herpetic neuralgia: Discrepancies between direct and indirect meta-analyses of randomized controlled trials J Gen Intern Med 24 2009 178 188
16. R. Chou, G.J. Fanciullo, P.G. Fine, J.A. Adler, J.C. Ballantyne, P. Davies, M.I. Donovan, D.A. Fishbain, K.M. Foley, J. Fudin, A.M. Gilson, A. Kelter, A. Mauskop, P.G. O'Connor, S.D. Passik, G.W. Pasternak, R.K. Portenoy, B.A. Rich, R.G. Roberts, K.H. Todd, C. Miaskowski American Pain Society-American Academy of Pain Medicine Opioids Guidelines Panel Clinical guidelines for the use of chronic opioid therapy in chronic noncancer pain J Pain 10 2009 113 130
17. P.S. Davies, and B.S. Galer Review of lidocaine patch 5% studies in the treatment of postherpetic neuralgia Drugs 64 2004 937 947 (Pubitemid 38608473)
18. R.H. Dworkin, A.B. O'Connor, M. Backonja, J.T. Farrar, N.B. Finnerup, T.S. Jensen, E.A. Kalso, J.D. Loeser, C. Miaskowski, T.J. Nurmikko, R.K. Portenoy, A.S. Rice, B.R. Stacey, R.D. Treede, D.C. Turk, and M.S. Wallace Pharmacologic management of neuropathic pain: Evidence-based recommendations Pain 132 2007 237 251 (Pubitemid 350051570)
19. R.H. Dworkin, R.L. Barbano, S.K. Tyring, R.F. Betts, M.P. McDermott, J. Pennella-Vaughan, G.J. Bennett, E. Berber, J.W. Gnann, C. Irvine, C. Kamp, K. Kieburtz, M.B. Max, and K.E. Schmader A randomized, placebo-controlled trial of oxycodone and of gabapentin for acute pain in herpes zoster Pain 142 2009 209 217
20. E. Eisenberg, E. McNicol, and D.B. Carr Opioids for neuropathic pain Cochrane Database Syst Rev 3 2006 CD006146
21. D.M. Fick, J.W. Cooper, W.E. Wade, J.L. Waller, J.R. Maclean, and M.H. Beers Updating the Beers criteria for potentially inappropriate medication use in older adults: Results of a US consensus panel of experts Arch Intern Med 163 2003 2716 2724 (Pubitemid 37517412)
22. P.G. Fine, and R.K. Portenoy Establishing "best practices" for opioid rotation: Conclusions of an expert panel J Pain Symptom Manage 38 2009 418 425
23. N.B. Finnerup, S.H. Sindrup, and T.S. Jensen The evidence for pharmacological treatment of neuropathic pain Pain 150 2010 573 581
24. A.D. Furlan, J.A. Sandoval, A. Mailis-Gagnon, and E. Tunks Opioids for chronic noncancer pain: A meta-analysis of effectiveness and side effects CMAJ 174 2006 1589 1594 (Pubitemid 43829515)
25. T.K. Gandhi, S.N. Weingart, J. Borus, A.C. Seger, J. Peterson, E. Burdick, D.L. Seger, K. Shu, F. Federico, L.L. Leape, and D.W. Bates Adverse drug events in ambulatory care N Engl J Med 348 2003 1556 1564 (Pubitemid 36437933)
26. F. Goodyear-Smith, and J. Halliwell Anticonvulsants for neuropathic pain: Gaps in the evidence Clin J Pain 25 2009 528 536
27. M. Gore, E. Dukes, D. Rowbotham, K.S. Tai, and D.L. Leslie Prevalence of contraindicated medical conditions and use of precluded medications in patients with painful neuropathic disorders prescribed amitriptyline Pain Pract 6 2006 265 272 (Pubitemid 44920926)
28. M. Gore, E. Dukes, D.J. Rowbotham, K.S. Tai, and D. Leslie Clinical characteristics and pain management among patients with painful peripheral neuropathic disorders in general practice settings Eur J Pain 11 2007 652 664 (Pubitemid 46818059)
29. J.T. Hanlon, S.L. Aspinall, T.P. Semla, S.D. Weisbord, L.F. Fried, C.B. Good, M.J. Fine, R.A. Stone, M.J. Pugh, M.I. Rossi, and S.M. Handler Consensus guidelines for oral dosing of primarily renally cleared medications in older adults J Am Geriatr Soc 57 2009 335 340
30. G. Hans, R. Sabatowski, A. Binder, I. Boesl, P. Rogers, and R. Baron Efficacy and tolerability of a 5% lidocaine medicated plaster for the topical treatment of post-herpetic neuralgia: Results of a long-term study Curr Med Res Opin 25 2009 1295 1305
31. J.D. Harris Management of expected and unexpected opioid-related side effects Clin J Pain 24 2008 S8 S13
32. Hollingshead J, Duhmke RM, Cornblath DR: Tramadol for neuropathic pain. Cochrane Database Syst Rev 3:CD003726, 2006
33. J.W. Jefferson, J.H. Greist, and D. Tunali Depression and antidepressants: A guide 6th ed. 2009 Madison Institute of Medicine Madison, WI
34. T.S. Jensen Opioids in the brain: Supraspinal mechanisms in pain control Acta Anaesthesiol Scand 41 1997 123 132 (Pubitemid 27072915)
35. E. Kadiev, V. Patel, P. Rad, L. Thankachan, A. Tram, M. Weinlein, K. Woodfin, R.B. Raffa, and S. Nagar Role of pharmacogenetics in variable response to drugs: Focus on opioids Expert Opin Drug Metab Toxicol 4 2008 77 91 (Pubitemid 351234102)
36. D.K. Kajdasz, S. Iyengar, D. Desaiah, M.M. Backonja, J.T. Farrar, D.A. Fishbain, T.S. Jensen, M.C. Rowbotham, C.N. Sang, D. Ziegler, and H.J. McQuay Duloxetine for the management of diabetic peripheral neuropathic pain: Evidence-based findings from post hoc analysis of three multicenter, randomized, double-blind, placebo-controlled, parallel-group studies Clin Ther 29 Suppl 2007 2536 2546 (Pubitemid 350299457)
37. Lunn MP, Hughes RA, Wiffen PJ: Duloxetine for treating painful neuropathy or chronic pain. Cochrane Database Syst Rev:CD007115, 2009
38. G.A. Mackin Medical and pharmacologic management of upper extremity neuropathic pain syndromes J Hand Ther 10 1997 96 109
39. T. Meier, G. Wasner, M. Faust, T. Kuntzer, F. Ochsner, M. Hueppe, J. Bogousslavsky, and R. Baron Efficacy of lidocaine patch 5% in the treatment of focal peripheral neuropathic pain syndromes: A randomized, double-blind, placebo-controlled study Pain 106 2003 151 158 (Pubitemid 37329625)
40. Moore RA, Straube S, Wiffen PJ, Derry S, McQuay HJ: Pregabalin for acute and chronic pain in adults. Cochrane Database Syst Rev:CD007076, 2009
41. S. Nalamachu, R.S. Crockett, A.R. Gammaitoni, and E.M. Gould A comparison of the lidocaine patch 5% vs naproxen 500 mg twice daily for the relief of pain associated with carpal tunnel syndrome: A 6-week, randomized, parallel-group study MedGenMed 8 2006 33 44
42. A.B. O'Connor, and R.H. Dworkin Treatment of neuropathic pain: An overview of recent guidelines Am J Med 122 2009 S22 S32
43. J. Pergolizzi, R.H. Boger, K. Budd, A. Dahan, S. Erdine, G. Hans, H.G. Kress, R. Langford, R. Likar, R.B. Raffa, and P. Sacerdote Opioids and the management of chronic severe pain in the elderly: Consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone) Pain Pract 8 2008 287 313
44. J.V. Pergolizzi, R.B. Raffa, and E. Gould Considerations on the use of oxymorphone in geriatric patients Expert Opin Drug Saf 8 2009 603 613
45. C. Rains, and H.M. Bryson Topical capsaicin. A review of its pharmacological properties and therapeutic potential in post-herpetic neuralgia, diabetic neuropathy and osteoarthritis Drugs Aging 7 1995 317 328
46. J.F. Rogers, A.N. Nafziger, and J.S. Bertino Jr. Pharmacogenetics affects dosing, efficacy, and toxicity of cytochrome P450-metabolized drugs Am J Med 113 2002 746 750 (Pubitemid 36044701)
47. Saarto T, Wiffen PJ: Antidepressants for neuropathic pain. Cochrane Database Syst Rev:CD005454, 2007
48. R.C. Sachdeo, A. Wasserstein, P.J. Mesenbrink, and J. D'Souza Effects of oxcarbazepine on sodium concentration and water handling Ann Neurol 51 2002 613 620
49. S. Straube, S. Derry, R.A. Moore, and H.J. McQuay Pregabalin in fibromyalgia: Meta-analysis of efficacy and safety from company clinical trial reports Rheumatology (Oxford) 49 2010 706 715
50. H. Sylliaas, G. Idland, L. Sandvik, L. Forsen, and A. Bergland Does mortality of the aged increase with the number of falls? Results from a nine-year follow-up study Eur J Epidemiol 24 2009 351 355
51. R.D. Treede, T.S. Jensen, J.N. Campbell, G. Cruccu, J.O. Dostrovsky, J.W. Griffin, P. Hansson, R. Hughes, T. Nurmikko, and J. Serra Neuropathic pain: Redefinition and a grading system for clinical and research purposes Neurology 70 2008 1630 1635 (Pubitemid 351620320)
52. U.S. Food and Drug Administration. Xanodyne agrees to withdraw propoxyphene from the U.S. market. FDA News Release, Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm234350.htm. Accessed December 1, 2010
53. D.K. Weiner, J.T. Hanlon, and S.A. Studenski Effects of central nervous system polypharmacy on falls liability in community-dwelling elderly Gerontology 44 1998 217 221 (Pubitemid 28305943)
54. W.T. White, N. Patel, M. Drass, and S. Nalamachu Lidocaine patch 5% with systemic analgesics such as gabapentin: A rational polypharmacy approach for the treatment of chronic pain Pain Med 4 2003 321 330
55. Wiffen P, Collins S, McQuay H, Carroll D, Jadad A, Moore A: Anticonvulsant drugs for acute and chronic pain. Cochrane Database Syst Rev:CD001133, 2000
56. Wiffen PJ, McQuay HJ, Edwards JE, Moore RA: Gabapentin for acute and chronic pain. Cochrane Database Syst Rev:CD005452, 2005
57. H. Wynne Drug metabolism and ageing J Br Menopause Soc 11 2005 51 56 (Pubitemid 40872876)
58. J. Zacher, R. Altman, N. Bellamy, P. Brühlmann, J. Da Silva, E. Huskisson, and R.S. Taylor Topical diclofenac and its role in pain and inflammation: An evidence-based review Curr Med Res Opin 24 2008 925 950 (Pubitemid 351579151)